Internal Medicine, Critical Care Medicine · Chicago, IL
NPI
1932224441
Since 2007
Specialty
Internal Medicine, Critical Care Medicine
Code 207RC0200X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
676 N Saint Clair St Ste 2100
Chicago, IL, 60611
Phone (312) 695-1800
Groups this clinician bills Medicare through
Medicare paid, 2024
$93K
781 services
Medicare patients, 2024
306
Average age 71
Drug cost, 2024
$16.5M
2,228 prescriptions
Company payments, 2025
$105K
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael J Cuttica was code 99215 (office e&m - established), 229 times for 164 patients. In total Michael J Cuttica billed 781 services in 23 codes, and Medicare paid $93K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-04-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 229 | 164 | $144.09 | $33K |
| 99291 Critical Care E&M | Facility | 163 | 56 | $184.41 | $30K |
| 94618 Pulmonary Function Testing | Office | 67 | 61 | $28.35 | $1,899 |
| 99205 Office E&M - New | Office | 66 | 66 | $176.38 | $12K |
| 99233 Hospital E&M - Subsequent | Facility | 57 | 38 | $101.56 | $5,789 |
| 99232 Hospital E&M - Subsequent | Facility | 30 | 25 | $67.44 | $2,023 |
| 99443 Telephone Services | Office | 25 | 21 | $100.99 | $2,525 |
| 99214 Office E&M - Established | Office | 20 | 18 | $106.54 | $2,131 |
By year: 2022 $108K for 833 services; 2023 $83K for 770 services; 2024 $93K for 781 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michael J Cuttica prescribed most often to Medicare patients was Sildenafil Citrate, with 338 prescriptions and refills. In total Michael J Cuttica wrote 2,228 Medicare prescriptions that cost $16.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Sildenafil Citrate Generic | 338 | 424 | 52 | $102K |
| Opsumit Macitentan | 332 | 332 | 38 | $4.2M |
| Ambrisentan Generic | 239 | 259 | 27 | $923K |
| Orenitram Er Treprostinil Diolamine | 223 | 223 | 16 | $4.9M |
| Tadalafil Generic | 207 | 207 | 22 | $174K |
| Adempas Riociguat | 175 | 175 | 21 | $2.4M |
| Tyvaso Dpi Treprostinil | 83 | 92 | 12 | $2.3M |
| Eliquis Apixaban | 80 | 157 | 19 | $90K |
| Furosemide Generic | 66 | 141 | 18 | $580 |
| Uptravi Selexipag | 33 | 33 | Under 11 | $892K |
| Incruse Ellipta Umeclidinium Bromide | 30 | 30 | Under 11 | $11K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 29 | 35 | Under 11 | $22K |
| Spiriva Respimat Tiotropium Bromide | 29 | 35 | Under 11 | $18K |
| Spironolactone Generic | 25 | 63 | Under 11 | $530 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 24 | 24 | Under 11 | $11K |
Brand drugs: 1,155 claims; generic drugs: 1,073 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael J Cuttica $105K ($105K in general payments such as food, travel and fees) from 6 companies. The largest payer was United Therapeutics Corporation with $47K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.